| Literature DB >> 29753795 |
Jabril Eldufani1, Alireza Nekoui2, Gilbert Blaise3.
Abstract
Ketamine is considered a dissociative anesthetic medication, and it is commonly administered by a parenteral route. It works mainly by blocking the N-methyl-D-aspartate receptor. It inhibits the voltage-gated Na and K channels and serotonin and dopamine reuptake; also, it affects specific receptors, such as α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, kainate, and aminobutyric acid A receptors. Ketamine appears to have particular mechanisms that are potentially involved during analgesic induction, including enhancing of descending inhibition and antiinflammatory effects. More recently, it has been shown that ketamine has potential in clinical practice for the management of chronic pain, cognitive function, depression, acute brain injury, and disorders of the immune system.Entities:
Keywords: Brain injury; Chronic pain; Depression; Immune system; Ketamine; N-methyl-d-aspartate receptor antagonist
Mesh:
Substances:
Year: 2018 PMID: 29753795 DOI: 10.1016/j.amjmed.2018.04.029
Source DB: PubMed Journal: Am J Med ISSN: 0002-9343 Impact factor: 4.965